Epoetin kappa
As of the edition of 20 October 2026, Epoetin kappa is a protein: marketed, first approved in 2010 (JP).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2010
- Kind
- Protein
- Brand name
- Epoetin Alfa BS
- First approved
- 20 January 2010 (JP)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- JCR Pharmaceuticals
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| JCR Pharmaceuticals | Applicant | 2010 to now |